309 related articles for article (PubMed ID: 35210989)
1. Imaging of Reactive Astrogliosis by Positron Emission Tomography.
Harada R; Furumoto S; Kudo Y; Yanai K; Villemagne VL; Okamura N
Front Neurosci; 2022; 16():807435. PubMed ID: 35210989
[TBL] [Abstract][Full Text] [Related]
2. [Imaging of neuropathology by PET tracers].
Harada R
Nihon Yakurigaku Zasshi; 2022; 157(6):453-457. PubMed ID: 36328560
[TBL] [Abstract][Full Text] [Related]
3. Characterization of monoamine oxidase-B (MAO-B) as a biomarker of reactive astrogliosis in Alzheimer's disease and related dementias.
Jaisa-Aad M; Muñoz-Castro C; Healey MA; Hyman BT; Serrano-Pozo A
Acta Neuropathol; 2024 Apr; 147(1):66. PubMed ID: 38568475
[TBL] [Abstract][Full Text] [Related]
4. First-in-Humans Evaluation of
Villemagne VL; Harada R; Doré V; Furumoto S; Mulligan R; Kudo Y; Burnham S; Krishnadas N; Bozinovski S; Huang K; Lopresti BJ; Yanai K; Rowe CC; Okamura N
J Nucl Med; 2022 Oct; 63(10):1551-1559. PubMed ID: 35086898
[TBL] [Abstract][Full Text] [Related]
5.
Harada R; Hayakawa Y; Ezura M; Lerdsirisuk P; Du Y; Ishikawa Y; Iwata R; Shidahara M; Ishiki A; Kikuchi A; Arai H; Kudo Y; Yanai K; Furumoto S; Okamura N
J Nucl Med; 2021 Feb; 62(2):253-258. PubMed ID: 32646880
[TBL] [Abstract][Full Text] [Related]
6. [In vivo imaging of astrogliosis by PET].
Harada R; Okamura N
Nihon Yakurigaku Zasshi; 2023; 158(1):26-29. PubMed ID: 36596483
[TBL] [Abstract][Full Text] [Related]
7. Assessing Reactive Astrogliosis with
Villemagne VL; Harada R; Doré V; Furumoto S; Mulligan R; Kudo Y; Burnham S; Krishnadas N; Bourgeat P; Xia Y; Laws S; Bozinovski S; Huang K; Ikonomovic MD; Fripp J; Yanai K; Okamura N; Rowe CC
J Nucl Med; 2022 Oct; 63(10):1560-1569. PubMed ID: 35086892
[TBL] [Abstract][Full Text] [Related]
8. Astroglial Responses to Amyloid-Beta Progression in a Mouse Model of Alzheimer's Disease.
Olsen M; Aguilar X; Sehlin D; Fang XT; Antoni G; Erlandsson A; Syvänen S
Mol Imaging Biol; 2018 Aug; 20(4):605-614. PubMed ID: 29297157
[TBL] [Abstract][Full Text] [Related]
9. Multitracer Approach to Understanding the Complexity of Reactive Astrogliosis in Alzheimer's Brains.
Fontana IC; Kumar A; Okamura N; Nordberg A
ACS Chem Neurosci; 2024 Jan; 15(2):328-336. PubMed ID: 38133820
[TBL] [Abstract][Full Text] [Related]
10. Tau imaging with [
Ishiki A; Harada R; Okamura N; Tomita N; Rowe CC; Villemagne VL; Yanai K; Kudo Y; Arai H; Furumoto S; Tashiro M; Furukawa K
Eur J Neurol; 2017 Jan; 24(1):130-136. PubMed ID: 27797445
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and evaluation of 2-pyrrolopyridinylquinoline derivatives as selective tau PET tracers for the diagnosis of Alzheimer's disease.
Lerdsirisuk P; Harada R; Hayakawa Y; Shimizu Y; Ishikawa Y; Iwata R; Kudo Y; Okamura N; Furumoto S
Nucl Med Biol; 2021 Feb; 93():11-18. PubMed ID: 33221641
[TBL] [Abstract][Full Text] [Related]
12. In vivo [18F]THK-5351 imaging detected reactive astrogliosis in argyrophilic grain disease with comorbid pathology: A clinicopathological study.
Kobayashi R; Nakamura T; Naganuma F; Harada R; Morioka D; Kanoto M; Furumoto S; Kudo Y; Kabasawa T; Otani K; Futakuchi M; Kawakatsu S; Okamura N
J Neuropathol Exp Neurol; 2023 Apr; 82(5):427-437. PubMed ID: 36882045
[TBL] [Abstract][Full Text] [Related]
13. The Role of Chirality of [
Harada R; Shimizu Y; Du Y; Ishikawa Y; Iwata R; Kudo Y; Yanai K; Okamura N; Furumoto S
ACS Chem Neurosci; 2022 Feb; 13(3):322-329. PubMed ID: 35049267
[TBL] [Abstract][Full Text] [Related]
14. [
Ballweg A; Klaus C; Vogler L; Katzdobler S; Wind K; Zatcepin A; Ziegler SI; Secgin B; Eckenweber F; Bohr B; Bernhardt A; Fietzek U; Rauchmann BS; Stoecklein S; Quach S; Beyer L; Scheifele M; Simmet M; Joseph E; Lindner S; Berg I; Koglin N; Mueller A; Stephens AW; Bartenstein P; Tonn JC; Albert NL; Kümpfel T; Kerschensteiner M; Perneczky R; Levin J; Paeger L; Herms J; Brendel M
J Neuroinflammation; 2023 Mar; 20(1):68. PubMed ID: 36906584
[TBL] [Abstract][Full Text] [Related]
15. The development and validation of tau PET tracers: current status and future directions.
Okamura N; Harada R; Ishiki A; Kikuchi A; Nakamura T; Kudo Y
Clin Transl Imaging; 2018; 6(4):305-316. PubMed ID: 30148121
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Monoamine Oxidase-A, Aβ Plaques, Tau, and Translocator Protein Levels in Postmortem Human Alzheimer's Disease Brain.
Syed AU; Liang C; Patel KK; Mondal R; Kamalia VM; Moran TR; Ahmed ST; Mukherjee J
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445985
[TBL] [Abstract][Full Text] [Related]
17. Novel 18F-labeled arylquinoline derivatives for noninvasive imaging of tau pathology in Alzheimer disease.
Okamura N; Furumoto S; Harada R; Tago T; Yoshikawa T; Fodero-Tavoletti M; Mulligan RS; Villemagne VL; Akatsu H; Yamamoto T; Arai H; Iwata R; Yanai K; Kudo Y
J Nucl Med; 2013 Aug; 54(8):1420-7. PubMed ID: 23857514
[TBL] [Abstract][Full Text] [Related]
18. Autoradiography validation of novel tau PET tracer [F-18]-MK-6240 on human postmortem brain tissue.
Aguero C; Dhaynaut M; Normandin MD; Amaral AC; Guehl NJ; Neelamegam R; Marquie M; Johnson KA; El Fakhri G; Frosch MP; Gomez-Isla T
Acta Neuropathol Commun; 2019 Mar; 7(1):37. PubMed ID: 30857558
[TBL] [Abstract][Full Text] [Related]
19. Neuroimaging-pathological correlations of [
Ishiki A; Harada R; Kai H; Sato N; Totsune T; Tomita N; Watanuki S; Hiraoka K; Ishikawa Y; Funaki Y; Iwata R; Furumoto S; Tashiro M; Sasano H; Kitamoto T; Kudo Y; Yanai K; Furukawa K; Okamura N; Arai H
Acta Neuropathol Commun; 2018 Jun; 6(1):53. PubMed ID: 29958546
[TBL] [Abstract][Full Text] [Related]
20. Astrocyte Signature in Alzheimer's Disease Continuum through a Multi-PET Tracer Imaging Perspective.
Fontana IC; Scarpa M; Malarte ML; Rocha FM; Ausellé-Bosch S; Bluma M; Bucci M; Chiotis K; Kumar A; Nordberg A
Cells; 2023 May; 12(11):. PubMed ID: 37296589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
